Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Aug;52(3):574-575.
doi: 10.1111/apt.15886.

Letter: liver disease and COVID-19-not the perfect storm. Authors' reply"

Isabel Garrido  1   2 , Rodrigo Liberal  1   2 , Guilherme Macedo  1   2
Affiliations
Comment

Letter: liver disease and COVID-19-not the perfect storm. Authors' reply"

Isabel Garrido et al. Aliment Pharmacol Ther. 2020 Aug.

Abstract

LINKED CONTENT

This article is linked to Garrido et al and Nathwani et al papers. To view these articles, visit https://doi.org/10.1111/apt.15813 and https://doi.org/10.1111/apt.15872.

PubMed Disclaimer

Comment on

  • Letter: liver disease and COVID-19-not the perfect storm.
    Nathwani R, Mukherjee S, Forlano R, Mullish BH, Vergis N, Selvapatt N, Manousou P, Nayagam S, Lemoine M, Dhar A. Nathwani R, et al. Aliment Pharmacol Ther. 2020 Aug;52(3):572-574. doi: 10.1111/apt.15872. Aliment Pharmacol Ther. 2020. PMID: 32656833 Free PMC article.

References

    1. Nathwani R, Mukherjee S, Forlano R, et al. Letter: liver disease and COVID‐19 ‐ not the perfect storm. Aliment Pharmacol Ther. 2020;52:572‐574. - PMC - PubMed
    1. Garrido I, Liberal R, Macedo G. Review article: Covid‐19 and liver disease – what we know on 1st May 2020. Aliment Pharmacol Ther. 2020;52;267-272. 10.1111/apt.15813 - DOI - PMC - PubMed
    1. Oyelade T, Alqahtani J, Canciani G. Prognosis of COVID‐19 in patients with liver and kidney diseases: an early systematic review and meta‐analysis. Trop Med Infect Dis. 2020;5:E80. - PMC - PubMed
    1. Moon AM, Webb GJ, Aloman C, et al. High mortality rates for SARS‐CoV‐2 infection in patients with pre‐existing chronic liver disease and cirrhosis: preliminary results from an international registry. J Hepatol. 2020. 10.1016/j.jhep.2020.05.013 - DOI - PMC - PubMed
    1. Singh S, Khan A. Clinical characteristics and outcomes of COVID‐19 among patients with pre‐existing liver disease in United States: a multi‐center research network study. Gastroenterology. 2020. 10.1053/j.gastro.2020.04.064 - DOI - PMC - PubMed

LinkOut - more resources